Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Margit Jeschke is currently leading the global Analytical Stewardship & CMC Product Sciences section within Novartis Cell & Gene Technical Development & Manufacturing.
In her current position she is responsible for the analytical development strategy of the company’s Cell & Gene Therapy products including overall product control strategy, specification setting, comparability studies, as well as CMC correlational sciences. Margit joined CGT in 2012 after holding several positions of increasing responsibility within Novartis Biopharmaceutical Development including leading Analytical Research & Development of Novartis Biologics in Basel. She spent two years in New Jersey building up and leading the CGT Technical Development unit co-located at the manufacturing plant in Morris Plains enabling manufacturing and commercialization of CTL019/Kymriah.
Margit holds a Ph.D. in Biochemistry from the University of Basel, Switzerland.